An overview of a cohort of South African patients with mitochondrial disorders

[1]  R. Khusainova,et al.  A Mitochondrial Etiology of Neurodegenerative Diseases: Evidence from Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.

[2]  N. Blau,et al.  Laboratory guide to the methods in biochemical genetics , 2008 .

[3]  E. Shoubridge,et al.  Long-term Outcome and Clinical Spectrum of 73 Pediatric Patients With Mitochondrial Diseases , 2007, Pediatrics.

[4]  R. Rodenburg,et al.  Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. , 2007, Clinical chemistry.

[5]  D. T. Loots,et al.  Amino-acid depletion induced by abnormal amino-acid conjugation and protein restriction in isovaleric acidemia , 2007, European Journal of Clinical Nutrition.

[6]  T. Bourgeron,et al.  Clinical presentation of mitochondrial disorders in childhood , 1996, Journal of Inherited Metabolic Disease.

[7]  Robert W. Taylor,et al.  The epidemiology of mitochondrial disorders--past, present and future. , 2004, Biochimica et biophysica acta.

[8]  J. Belmont,et al.  Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease , 2004, Pediatrics.

[9]  N. Howell,et al.  An evolutionary perspective on pathogenic mtDNA mutations: haplogroup associations of clinical disorders. , 2004, Mitochondrion.

[10]  J. Smeitink,et al.  Mitochondrial disorders: Clinical presentation and diagnostic dilemmas , 2003, Journal of Inherited Metabolic Disease.

[11]  J. Zeman,et al.  The Clinical Spectrum of Mitochondrial Disease in 75 Pediatric Patients , 2003, Clinical pediatrics.

[12]  D. Thorburn,et al.  Minimum birth prevalence of mitochondrial respiratory chain disorders in children. , 2003, Brain : a journal of neurology.

[13]  J. Smeitink,et al.  Mitochondrial disorders , 2002, Neurology.

[14]  E. Starikovskaya,et al.  The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J , 2002, Human Genetics.

[15]  N. Bresolin,et al.  Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation , 2001, Journal of Neurology.

[16]  A. Munnich,et al.  Clinical spectrum and diagnosis of mitochondrial disorders. , 2001, American journal of medical genetics.

[17]  E. Holme,et al.  The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities , 2001, Annals of neurology.

[18]  Alisa R Gutman,et al.  Multiple presentation of mitochondrial disorders , 1999, Archives of disease in childhood.

[19]  J. Christodoulou,et al.  Leigh syndrome: Clinical features and biochemical and DNA abnormalities , 1996, Annals of neurology.

[20]  M. Durán,et al.  Urinary excretion of homocitric acid and methylhomocitric acid in propionic acidaemia: minor metabolic products of the citrate synthase aldol condensation reaction. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[21]  K. Gibson,et al.  The detection of 3-methylglutarylcarnitine and a new dicarboxylic conjugate, 3-methylglutaconylcarnitine, in 3-methylglutaconic aciduria. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[22]  James Stephen Marron,et al.  Kernel Quantile Estimators , 1990 .

[23]  P. Garland,et al.  The kinetic properties of citrate synthase from rat liver mitochondria. , 1969, The Biochemical journal.